Basecamp Wealth Advisors’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.9K Buy
+76
New +$12.3K ﹤0.01% 854

Other funds holding BLTE

Basecamp Wealth Advisors's BLTE Position: Q3 2026 in Review

Basecamp Wealth Advisors opened a new position in Belite Bio (BLTE) in Q3 2026: 76 shares worth $12.9K. The stake represents ﹤0.01% of the portfolio and ranks #854 among its holdings.

96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Basecamp Wealth Advisors held 76 shares of Belite Bio worth $12.9K as of Q3 2026.
  • Belite Bio was a new Basecamp Wealth Advisors position in Q3 2026.
  • Belite Bio made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q3 2026, its #854 holding.
  • 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.